ANI Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and s…

Drug Manufacturers - Specialty & Generic
US, Baudette [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

ANI Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ANIP's Analysis
CIK: 1023024 CUSIP: 00182C103 ISIN: US00182C1036 LEI: - UEI: -
Secondary Listings
ANIP has no secondary listings inside our databases.